82W.DU Hims & Hers Health Inc
Company Analysis
Latest News
🟢 Hims & Hers Health is trading 4.50% up today with no clear immediate reason
Hims & Hers Health is trading at €28.80, up +4.50%, while the immediate reason for the gain remains unclear. - No confirmed August 24, 2026 company-specific...
🟢 Hims & Hers Health is trading 9.02% up today with no confirmed immediate catalyst
Hims & Hers Health is trading at €27.56, +9.02%, with the immediate catalyst unconfirmed. - No new company-specific announcement clearly explains the August...
🟢 Hims & Hers Health is trading 5.33% up today amid a broad healthcare-sector rally
Hims & Hers Health is trading 5.33% up at €25.28 after participating in a broad healthcare-sector rally. - Healthcare stocks benefited from Moderna’s sharp...
🟢 Hims & Hers Health is trading 5% up today amid a broad healthcare-sector rally
Hims & Hers Health is trading 5.33% up at €25.28, alongside a broad healthcare-sector rally. - Healthcare stocks are benefiting from stronger earnings...
🔴 Hims & Hers Health is trading 4% down today after wider-than-expected Q2 loss
Hims & Hers Health is trading at €25.62, down -4.04%, after reporting a wider-than-expected Q2 GAAP loss of $0.37 per share versus a $0.05 estimate. - Revenue...
🔴 Hims & Hers Health is trading 4% down today after a $0.37 GAAP loss
Hims & Hers Health is trading 4% down at €25.64 after its August 10, 2026 second-quarter report showed a $0.37 GAAP loss per share, versus a $0.05 estimate. -...
🔴 Hims & Hers Health is trading 6.92% down today after reporting a $0.37 GAAP loss per share
Hims & Hers Health is trading 6.92% down at €25.54 after its August 10, 2026 second-quarter report showed a $0.37 GAAP loss per share, versus a $0.05...
🟢 Hims & Hers Health is trading 3.78% up as investors reassess FTC lawsuit allegations
Hims & Hers Health is trading at €26.88, up +3.78% as investors reassess the FTC lawsuit allegations. - Shares continued recovering from the July 29 FTC...
🟢 Hims & Hers Health is trading 3.71% up today as investors reassess FTC lawsuit impact
Hims & Hers Health is trading at €26.86, 3.71% up now as investors reassess the impact of the FTC lawsuit. - The August 7 rally followed the stock’s recovery...
Hims & Hers Rebounds 16% From FTC Lawsuit Low — But Can a Company Under Federal Scrutiny and Bleeding Cash Sustain Investor Confidence?
Shares of Hims & Hers Health surged 9.5% to €26.18 on August 7, extending a sharp rebound that has now clawed back all losses — and then some — from the FTC...
Hims & Hers Rebounds 16% From FTC Lawsuit Low — But Can a Company Under Federal Scrutiny and Bleeding Cash Sustain Investor Confidence?
Shares of Hims & Hers Health surged 9.5% to €26.18 on August 7, extending a sharp rebound that has now clawed back all losses — and then some — from the FTC...
🔴 Hims & Hers Health is trading 4.07% down today as no company-specific catalyst is confirmed
Hims & Hers Health is trading 4.07% down at €25.90 after the August 6, 2026 session, with no confirmed company-specific catalyst identified. - The company...
🔴 Hims & Hers Health is trading 4% down today with no clear company-specific catalyst
Hims & Hers Health is trading 4.07% down at €25.90, with no clear company-specific catalyst explaining the August 6, 2026 decline. - The company announced a...
🟢 Hims & Hers Health Jumps 10.8% as GLP-1 Weight-Loss Boom Fuels Further Rebound
Hims & Hers Health is trading at €26.48 (+10.79%) today, driven by continued investor interest in the GLP-1 weight-loss market. • This surge extends a rebound...
🟢 Hims & Hers Health is trading 9.5% up today as rebound from FTC lawsuit selloff extends
Hims & Hers Health is trading 9.5% higher at €26.18 as investors extend a recovery following a sharp selloff triggered by an FTC lawsuit regarding marketing...
🟢 Hims & Hers Health is trading 3.6% up today as shares rebound from an FTC lawsuit-driven selloff
Hims & Hers Health is trading 3.6% up at €23.28 as the stock recovers from a sharp decline triggered by regulatory action. • Shares fell 10.51% to €22.48 on...
🟢 Hims & Hers Health is trading 3.6% up today as shares rebound after FTC lawsuit-driven selloff
Hims & Hers Health is trading 3.6% up at €23.28 today, rebounding from yesterday's sharp decline. • The stock fell 10.51% to €22.48 yesterday following the...
🔴 Hims & Hers Health is trading 10.51% down today after mixed FDA advisory vote on peptide products
Hims & Hers Health is trading at €22.48 (-10.51%) amid renewed pressure tied to FDA scrutiny of its peptide products. • The move follows a mixed FDA Pharmacy...
🔴 Hims & Hers Health is trading 10.5% down today after mixed FDA vote on peptide products
Hims & Hers Health is trading 10.5% down today at €22.48 as the stock continues to react to recent U.S. FDA scrutiny of its peptide products. • Shares are...
🔴 Hims & Hers Health is trading 3.2% down today amid ongoing FDA scrutiny of peptide products
Hims & Hers Health is trading 3.2% down today at €25.12 as the stock continues to digest volatility tied to recent FDA scrutiny of key peptide products. •...